The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study
Inflammation Research (2021) - Comments
pubmed: 34586459  doi: 10.1007/s00011-021-01507-5  issn: 1023-3830  issn: 1420-908x 

Nikita V. Lomakin, Bulat A. Bakirov, Denis N. Protsenko, Vadim I. Mazurov, Gaziyavdibir H. Musaev, Olga M. Moiseeva, Elena S. Pasechnik, Vladimir V. Popov, Elena A. Smolyarchuk, Ivan G. Gordeev, Mikhail Yu Gilyarov, Darya S. Fomina, Anton I. Seleznev, Yulia N. Linkova, Ekaterina A. Dokukina, Anna V. Eremeeva, Polina S. Pukhtinskaia, Maria A. Morozova, Arina V. Zinkina-Orikhan, Anton A. Lutckii